The next board meeting for Iovance Biotherapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
Iovance Biotherapeutics Inc has a share price target of US$ 9, revenue growth forecast of 68.0%, and profit growth estimate of -2.9% for FY25, based on top 12 analyst calls.